---
title: "Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Fluid Liquid Combination Diphtheria-Tetanus Toxoid-Five-Component Acellular Pertussis (DTaP5), Inactivated Poliovirus (IPV), and Haemophilus influenzae Type b (Hib) Vaccine Compared with a DTaP3-IPV/ Hib Vaccine Administered at 3, 5, and 12 Months of Age"
analyst: amantonio
article:
  type: article
  authors: Vesikari
  year: 2013
  journal: Clin Vaccine Immunol.
  link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807208/
  pubmed: PMC3807208
---

Clinical trials of pentavalent vaccines: Safety was tested for 30 days. 8.5% of infants had serious adverse events, almost all of them were not related to the vaccine.
